日程浏览 - CSC2022

Feasibility Exploration of Different Anti-angina Regimens Using Electronic Patient Reported Outcomes (ePRO) Tool: A Multicenter, Prospective Study (GREAT)

曾勇 10:20-10:25

首都医科大学附属北京安贞医院[论文发言]

提问和点评

10:25-10:27

[讨论]

Real-World Observational Study of Nicorandil Combined with Beta-blocker in Chinese Patients with Coronary Heart Disease

舒鸿洋 10:27-10:32

华中科技大学同济医学院[论文发言]

提问和点评

10:32-10:34

[讨论]

Digital Therapy for Rest Heart Rate Control In Coronary Artery Disease: a parallel-group, single-blind, randomised controlled trial

张鸥 10:34-10:39

清华大学附属北京清华长庚医院[论文发言]

提问和点评

10:39-10:41

[讨论]

Association of serum chromogranin B with left ventricular function in patients with stable angina undergoing successful recanalization for chronic total occlusion: Relation to collateral conditions

王晓群 10:41-10:46

上海交通大学医学院附属瑞金医院[论文发言]

提问和点评

10:46-10:48

[讨论]

The implication of left atrial volume index in patients with three-vessel coronary disease: a 6.6-year follow-up cohort study

刘如 10:48-10:53

中国医学科学院阜外医院（国家心血管病中心）[论文发言]

提问和点评

10:53-10:55

[讨论]

Development and validation of a novel risk score to predict 5-year mortality in patients with acute myocardial infarction in China: a retrospective study

唐艳 10:55-11:00

中南大学湘雅三医院[论文发言]

提问和点评

11:00-11:02

[讨论]

基于真实世界的缺血性心脑血管疾病共患的临床特征及卫生经济学评价

谢依热·哈木拉提 11:02-11:07

新疆医科大学第一附属医院[论文发言]

提问和点评

11:07-11:09

[讨论]

DeepCAG: Coronary angiography deep learning model for diagnosis of neoatheroslcerosis